[AI Supercharges Fentanyl Production And Distribution, Study Finds](https://wbbsec.com/opinions-and-features/ai-supercharges-fentanyl-production-and-distribution-study-finds/)
[AI Supercharges Fentanyl Production And Distribution, Study Finds](https://wbbsec.com/opinions-and-features/ai-supercharges-fentanyl-production-and-distribution-study-finds/)


WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of the Financial Industry Regulatory Authority, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

Our investment bank has participated in over 250 transactions leading to $4 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from its peers for its equity research and analytics year after year for accuracy and performance by the financial industry’s most highly regarded rankings organizations.

Investment Management

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

Equity Research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

Institutional Sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

Investment Banking

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.

M&A and Strategic Advisory

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.

Equity Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

Press Releases

View All

  • On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.” The forum will examine how responses to prior influenza pathogens predicated global responses to Covid.

  • For Immediate Release October 13, 2023 Cranford, NJ– On Thursday, October 19th, WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations, examining how responses to prior influenza pathogens predicated global responses to COVID. The event will feature experts, representing multiple disciplines and perspectives from around the world to consider what problems may lie ahead given our actions. The forum:  “A Tale of Two Pandemics: Lessons from the 1889 & 2019 Pandemics” will be moderated by Dr. Richard Marfuggi, a Medical Ethicist, Medical Historian, and Medical Director of the WBB Research Institute.  Distinguished participants include Corinne LeGoff, research scientist who will discuss the development of the Covid-19 mRNA vaccine and development of a DNA-based vaccine platform; Dr. Stijn Van Nieuwerburgh, Columbia University Graduate School of Business who will discuss the Realities of Commercial Real Estate – global economic and social repercussions; Dr. Alain Gagnon, Professor at the University of Montreal, discussing 1889 effects on 1918 and implications for 2019 and beyond; Dr. Gregory Wawro, Professor of Political Science, Columbia University School of Professional Studies to discuss political implications of the 1889 and 2019 pandemics and Dr. Steve Brozak, Founder & CEO of the WBB Research Institute to discuss economic consequences of the two pandemics. Due to security measures at the UN, attendees must pre-register for the event at –> https://www.eventbrite.com/e/a-tale-of-two-pandemics-lessons-from-the-1889-2019-pandemics-tickets-735921981457   About WBB Research Institute. The WBB Research Institute is a newly formed, independent, non-ideological, public policy research center fostering and applying specialized knowledge to a diverse range of health issues. The institute’s mission is to inform leaders in commerce, industry, government, and public policy about key issues emerging at the intersection of healthcare and industry.  The Institute presents and publishes seminars, discussions, articles, and studies to better enable leaders from government, media, and other involved interests to both inform the public and improve the quality of our lives. www.WBBRI.com About The Foreign Policy Association (FPA). The Foreign Policy Association is a non-profit organization, founded in 1918. The mission of the Foreign Policy Association today, as it has been throughout its 105-year history is to catalyze developing awareness, understanding, and informed opinion on U.S. foreign policy and global issues. Through its balanced, nonpartisan publications and programs, FPA encourages citizens to participate in the foreign policy process. www.fpa.org About The United Nations Institute for Training and Research (UNITAR) The United Nations Institute for Training and Research is a dedicated training arm of the United Nations system. UNITAR provides training and capacity development activities to assist mainly developing countries with special attention to Least Developed Countries (LDCs), Small Island Developing States (SIDS), and other groups and communities who are most vulnerable. www.unitar.org

  • On Friday, October 6, Steve Brozak, Managing Partner and President of WBB Securities will moderate a panel discussion titled: “Infectious Disease: From Neglect to Respect Made Possible by New Technologies” at the BioFuture forum in New York City. 

Opinions & Features

View All

  • According to Dr Steve Brozak, when AI mixes with illicit drug makers you have a real life “Breaking Bad” His piece on AI-facilitated illicit fentanyl production is a must read:

  • In his latest Forbes online commentary, Dr. Steve Brozak explains how the Fed’s decision to hold rates will affect U.S. healthcare. In this article, he describes how interest rates are a greater challenge to privately funded healthcare systems than to publicly funded models. He writes, “the more privately-oriented a country’s healthcare capital structure is, the more sensitive to changes in interest rates it will be.”

  • In his latest Forbes Online commentary, Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game, Steve Brozak describes how a class of drugs, intended to treat Type 2 diabetes patients, has become a fad drug for people who want to lose weight to look good. This has transformed the market for a drug intended for a specific purpose into a multi-billion dollar market and introduces the potential for serious, life-long disabilities afflicting millions of Americans.